NASDAQ:CDTX

Cidara Therapeutics Earning Date

USA |NASDAQ |USD

CDTX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.36 $0.18 $-0.41
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $2.94M $32.86M $2.42M

Cidara Therapeutics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

CDTX Earnings Date & History Chart

CDTX Earnings & Revenue Forecast

CDTX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.37 $-0.46 $-0.30
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.91 $-1.00 $-0.83
Dec 2022 6 $-1.41 $-1.69 $-1.17

CDTX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.36 $-0.33 $-0.33
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.93 $-1.08 $-1.08
Dec 2022 1 / 0 $-1.43 $-1.63 $-1.63

CDTX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $2.39M $1.00M $3.61M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $40.60M $39.00M $42.50M
Dec 2022 6 $6.37M $0.00 $11.86M

CDTX Earnings Date & Revenue History

CDTX Earnings History

|
Show More
Show More

CDTX Revenue History

|
Show More
Show More

Cidara Therapeutics Next Earnings Date & Report

CDTX Next Earnings Date & Report Preview: Sep 2021 (FQ)

CDTX's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Cidara Therapeutics's next quarterly earnings is $-0.36, with a low EPS estimation of $-0.40, and a high estimation of $-0.32.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.36, the last 2 month trend is $-0.31, and the 3 month trend is $-0.31.

Based on 4 analysts, the average revenue estimation is $2.94M, with a low revenue estimation of $1.80M, and a high estimation of $4.00M.

Cidara Therapeutics Previous Earnings Dates & Reports

CDTX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Cidara Therapeutics's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

CDTX's earnings per share (EPS) was $0.18, beating the consensus analysts forecast of $-0.23 by 178.26%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -146.15%, and higher than the same period a year before (Jun 2020) by -140.00%.

Revenues were $32.86M, better than the forecast of $18.20M by 80.57%, up by 1264.74% from the previous quarter , and up by 868.84% from the same period last year.

The company reported a net income of $10.71M.

Free cash flow for the quarter was $3.42M , compared to $-1.80M last quarter and $-14.17M a year before.

CDTX ended the quarter with $5.29M in total debt, a decrease of -20.21% compared to the previous quarter, and a decrease of -50.06% compared to the same quarter a year before.

CDTX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cidara Therapeutics's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

CDTX's earnings per share (EPS) was $-1.80, missing the consensus analysts forecast of $-1.54 by 16.88% , and lower than the previous year's EPS (Dec 2019) by 25.87%.

Revenues were $12.07M, worse than the forecast of $18.53M by -34.88%, and down by -42.30% from previous year's revenue.

The company reported a net income of $-72.11M.

Cidara Therapeutics reported a free cash flow of $-54.60M for its fiscal year, compared to $-28.57M a year ago.

The company ended the fiscal year with $7.96M in total debt, a decrease of -32.09% compared to the previous year.